External-application drug for treating rheumatic pain diseases and preparation method therefor

A technology of rheumatism pain and topical medicine, applied in the field of external combination medicine, can solve the problems of recurrence rate, high sequelae, and inability to obtain long-term therapeutic effect, etc., and achieve high cure rate, relieve joint pain, and fast curative effect

Inactive Publication Date: 2015-11-25
BEIJING RENJITANG HEALTH TECH CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical practice has proved that the recurrence rate and sequelae of these t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External-application drug for treating rheumatic pain diseases and preparation method therefor
  • External-application drug for treating rheumatic pain diseases and preparation method therefor
  • External-application drug for treating rheumatic pain diseases and preparation method therefor

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0017] Example 1:

[0018] The embodiments of the present invention are prepared from raw materials containing the following parts by weight:

[0019]

[0020] The above raw materials, of which Imperata cylindrica root, wild safflower, shamrock, madder, and clover are smashed into a paste, and the other raw materials are processed into powder, mixed and stirred to make an external medicine, and an appropriate amount is used on the affected area.

Example Embodiment

[0021] Example 2:

[0022] The embodiments of the present invention are prepared from raw materials containing the following parts by weight:

[0023]

[0024] The above raw materials, of which Imperata cylindrica root, wild safflower, shamrock, madder, and clover are smashed into a paste, and the other raw materials are processed into powder, mixed and stirred to make an external medicine, and an appropriate amount is used on the affected area.

Example Embodiment

[0025] Example 3:

[0026] The best embodiment of the present invention is prepared from raw materials containing the following parts by weight:

[0027]

[0028] The above raw materials, of which Imperata cylindrica root, wild safflower, shamrock, madder, and clover are smashed into a paste, and the other raw materials are processed into powder, mixed and stirred to make an external medicine, and an appropriate amount is used on the affected area.

[0029] The raw material of the external medicine of the present invention is the dried roots and rhizomes of Panaxnotoginseng (Burk.) FHChen, a plant of the family Araliaceae. It has the functions of dispelling blood stasis, stopping bleeding, reducing swelling and alleviating pain, and cures hemoptysis, vomiting blood, hemoptysis and hematochezia. , Metrorrhagia, traumatic bleeding, chest and abdomen tingling, swelling and pain. Imperata cylindrica root is the dried rhizome of imperatacylindricaBeauv.var.major (Nees) CEHubb. Stomach f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of external-application drugs and particularly relates to an external-application drug for treating rheumatic pain diseases. The drug is characterized by being prepared from the following raw materials in parts by weight: radix notoginseng, imperata rhizome, wild safflowers, thistle herb, radix rubiae, radix tetrastigme, radix clematidis, black-tail snake, rhizoma corydalis, semen sinapis, curcuma, pangolin scales, hirudo, cyathula officinalis, garden balsam stem and herba lycopodii. The drug is mainly used for treating pain from rheumatism, cervical and lumbar spondylosis and the like, takes the symptom alleviating strategy, i.e., clearing and activating the channels and collaterals and circulating Qi and blood so as to relax muscles and rapidly relieve arthralgia and takes the permanent cure strategy, i.e., removing dampness and arresting wind and removing blood stasis and removing toxicity so as to thoroughly eliminate environments generating blood stasis turbidity and stagnation.

Description

technical field [0001] The invention relates to a combination medicine for external use, in particular to a medicine for external use for treating rheumatic pain diseases and a preparation method thereof. Background technique [0002] Rheumatism is a group of diseases mainly invading joints, bones, muscles, blood vessels and related soft or connective tissues, most of which are autoimmune diseases. The onset is mostly hidden and slow, the course of the disease is long, and most of them have genetic predisposition. Diagnosis and treatment are difficult; different autoantibodies can be detected in the blood, which may be related to different HLA subtypes; there is a good short-term response to non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and immunosuppressants or long-term remission. [0003] Rheumatic pain diseases, lumbar spondylosis, cervical spondylosis, etc. are common clinical diseases. Conventional treatment methods include non-surgical treatment a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P19/00A61P29/00A61K35/62A61K35/36A61K35/583
Inventor 张羽
Owner BEIJING RENJITANG HEALTH TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap